Delivery Order SPE2DB20D1109-SPE2DB25FP67J
- Not listed
- The Defense Logistics Agency awarded a $8,453.04 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Durolane 60 mg/3 mL syringes. This firm fixed-price contract, with a completion date of July 29, 2025, represents a competitively awarded non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The products will be delivered to AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,347.52 by the Defense Logistics Agency on August 1, 2025, for Durolane 60 mg/3 mL syringes. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. Performance is scheduled for completion by August 4, 2025, with work to be performed at the contractor's Conshohocken facility. This delivery...
- The Defense Logistics Agency awarded a $6,112.30 delivery order to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract requires performance at the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a non-set-aside procurement action for this injectable pharmaceutical product used in joint pain treatment and osteoarthritis management. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on August 21, 2025. This competitively awarded, non-set-aside contract carries a ceiling value of $3,187.90 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,177.85 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $10,520.07 delivery order to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes. This is a firm fixed price contract with an ultimate completion date of July 28, 2025, representing a non-set-aside procurement awarded competitively on July 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $5.4K. This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $8,762.88. This is a firm fixed-price delivery order with no set-aside designation, executed through competitive procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The order represents a child...
- The Defense Logistics Agency awarded a $3,523.79 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Durolane 60 mg/3 mL syringes. This non-set-aside, firm fixed-price contract is scheduled for completion by August 12, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply requirements for military and defense healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $8,591.45 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract issued under AmerisourceBergen's larger...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP67JDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,965.97 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes on September 2, 2025, with completion expected by September 3, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Durolane is a hyaluronic acid-based intra-articular injection used for osteoarthritis treatment, representing a specialized pharmaceutical product within the company's broader medical supply portfolio. This delivery order operates under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to military and veteran healthcare systems. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill diverse medical commodity requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 9/2/25 |